Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry denotes a pseudogene with sequence similarity to the Dedicator of cytokinesis 1 (DOCK1), a protein involved in cytoskeletal dynamics, migration, and signaling[6]. Pseudogenes are genomic sequences resembling protein-coding genes but lacking protein-coding potential or function. Some pseudogenes can regulate gene expression by serving as miRNA sponges or producing regulatory RNAs[5][7], but most lack defined biological or clinical relevance. Therefore, this pseudogene is not a canonical therapeutic target, and little is known about its biological function or disease involvement. ENSG00000225795 ("pseudogene similar to part of dedicator of cytokinesis 1") is not a bona fide therapeutic target. It is a pseudogene that may carry regulatory potential but lacks evidence for biological function or clinical application[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of dedicator of cytokinesis 1 (ENSG00000225795).